Dr Kerri Beckmann is a cancer epidemiologist with an interest in the early detection and treatment of breast, prostate and colorectal cancer. She completed her PhD at the University of Adelaide, Australia in 2014. She is employed at the University of South Australia as a Research Fellow in the Cancer Epidemiology and Population Health Research Unit.
Kerri is the recipient of a Sydney Sax NHMRC Early Career Fellowship and is currently a Visiting Research Fellow at Kings College London working with the Translational Oncology and Urology Research Team.
Much of her current work is predominantly in the area of prostate cancer outcomes research. She has had a longstanding association with the South Australian Prostate Cancer Clinical Outcomes Collaborative and is involved in analysis of trends in clinical characteristics, treatment patterns and health outcomes using data from this clinical registry. She is also involved in other research projects the focus on patterns of care and outcomes for people affected by colorectal cancer and breast cancer.

Aug 09, 2024 18:31 pm UTC| Insights & Views Health
Every year more than 24,000 Australian men are diagnosed with prostate cancer, making it the most frequently diagnosed cancer among Australian men. Despite high survival rates around 96% of men diagnosed with prostate...